Suchergebnisse - "*Ritonavir"

PubPharm (1.726)

1

Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa

enthalten in: Clinical pharmacology and therapeutics | 2024

von Chupradit, S. | Wamalwa, D. | Maleche-Obimbo, E. | +11

2

Enteral administration of crushed rilpivirine in a patient with HIV : A case report

enthalten in: British journal of clinical pharmacology | 2024

von Ragonnet, G. | Laroche, H. | Néant, N. | +5

3

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1 : week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

enthalten in: The lancet. HIV | 2024

von Orkin, C. | Molina, J. | Cahn, P. | +112

4

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

5

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

6

Daily ritonavir-boosted darunavir for viral suppression in pregnancy (DRV-P)

enthalten in: HIV medicine | 2024

von Gacic, N. | Tulloch, K. | Money, D. | +1

7

Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults

enthalten in: British journal of clinical pharmacology | 2024

von Zhang, Y. | Joshi, S. | Yazdani, P. | +6

8

Factors associated with the acceptability of Lopinavir/Ritonavir formulations among children living with HIV/AIDS attending care and treatment clinics in Mbeya and Mwanza, Tanzania

enthalten in: PloS one | 2024

von Jiwa, N. | Ketang'enyi, E. | Nganyanyuka, K. | +12

9

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV) : an open-label, phase 2, randomised, controlled, adaptive trial

enthalten in: The Lancet. Infectious diseases | 2024

von Schilling, W. | Jittamala, P. | Watson, J. | +89

ErratumIn: Lancet Infect Dis. 2023 Dec;23(12):e511. - PMID 37839427

10

Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study) : an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

enthalten in: The lancet. HIV | 2024

von Bekker, A. | Salvadori, N. | Rabie, H. | +10

ErratumIn: Lancet HIV. 2024 Apr 5;:. - PMID 38588690

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[173]